Læknablaðið - 15.03.2004, Side 36

FRÆÐIGREINAR / KRANSÆÐAVÍKKANIR
An in vivo intravascular ultrasound study. Eur Heart J 1997;
18:1090-4.
15. Kwaan HC. Changes in blood coagulation, platelet function,
and plasminogen-plasmin system in diabetics. Diabetes 1992;
41 (Suppl 2); 32-5.
16. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD,
Parker CB, et al. The effect of diabetes mellitus on prognosis
and serial left ventricular function after acute myocardial
infarction: contribution of both coronary disease and diastolic
left ventricular dysfunction to the adverse prognosis. The
MILIS study group. J Am Coll Cardiol 1989; 14:49-57.
17. Zuanetti G, Lattini R, Maggioni AP, Santoro L, Franzosi MG.
Influence of diabetes on mortality in acute myocardial infarc-
tion: Data from GISSI-2 study. J Am Coll Cardiol 1993; 22:
1788-94.
18. Schaper W, Buschmann I. Collateral circulation in diabetes.
Circulation 1999; 99:2224-6.
19. Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol
EJ. Abciximab reduces mortality in diabetics following percu-
taneous coronary intervention. J Am Coll Cardiol 2000; 35:
922-8.
20. Marso SP, Lincoff AM, Ellis SG, Bhatt DL, Tanguay JF, Klei-
man NS, et al. Optimizing the percutaneous interventional
outcomes for patients with diabetes mellitus: results of the
EPISTENT (Evaluation of Platelet Ilb/IIIa Inhibitor for Sten-
ting Trial) diabetic substudy. Circulation 1999; 100: 2477-84.
21. Laskey WK, Selzer F, Vlachos HA, Johnston J, Jacobs A, King
SB et al. Comparison of in-hospital and one-year outcomes in
patients with and without diabetes mellitus undergoing percu-
taneous catheter intervention (From the National Heart, Lung
and Blood Institute Dynamic Registry). Am J Cardiology
2002; 90:1062-7.
22. Marso SP, Ellis SG, Tuzcu M, Withlow PL, Franco I, Raymond
RE, et al. The importance of proteinuria as a determinant of
outcome following percutaneous coronary revascularization
in diabetics. J Am Coll Cardiol 1999; 33:1269-77.
23. Elsner M, Walter D, Auch-Schwelk W, Schachinger V. Statin
therapy in diabetic patients is associated with reduced clinical
event rate and attenuated neointimal proliferation after coro-
nary stenting. Circulation 1999; 100:1365.
24. Van Belle E, Abolmaali K, Bauters C, McFadden EP, La-
blanche JM, Bertrand ME. Restenosis, late vessel occlusion
and left ventricular function six months after balloon angio-
plasty in diabetic patients. J Am Coll Cardiol 1999:34; 476-85.
25. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF,
Bucher TA, et al. Increased restenosis in diabetes mellitus
after coronary interventions is due to exaggerated intimal
hyperplasia. A serial intravascular ultrasound study. Circula-
tion 1997; 95:1366-9.
26. Van Belle E, Ketelers R, Bauters C, Perie M, Abolmaali K,
Richard F, et al. Patency of percutaneous transluminal coro-
nary angioplasty sites at 6-month angiographic follow-up: A
key determinant of survival in diabetics after coronary balloon
angioplasty. Circulation 2001; 103:1218-24.
27. Van Beile E, Bauters C, Hubert E, Bodrt JC, Abolmaalik K,
Meurice T, et al. Restenosis rates in diabetic patients: a com-
parison of coronary stenting and balloon angioplasty in native
coronary vessels. Circulation 1997; 96:1454-60.
28. Leon MB, Bakhai A. Drug-eluting stents and glycoprotein
Ilb/IIIa inhibitors: combination therapy for the future. Am
Heart J 2003; 146 (4 Suppl): S13-7.
29. Gowda MS, Vacek JL, Hallas D. One-year outcomes of dia-
betic versus nondiabetic patients with non-Q-wave acute myo-
cardial infarction treated with percutaneous transluminal
coronary angioplasty. Am J Cardiol 1998; 81:1067-71.
30. Adgey AA. An overview of results of clinical trials with glyco-
protein Ilb/IIIa inhibitors. Am Heart J 1998; 135: S43-55.
31. Roffi M, Molitemo DJ, Meier B, Powers ER, Grines CL, Di
Battiste PM, et al. Impact of different platelet glycoprotein
Ilb/IIIa receptor inhibitors among diabetic patients under-
going percutaneous coronary intervention: Do Tirofiban and
ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1
year follow-up. Circulation 2002; 105:2730-6.
32. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Nata-
rajan MK, et al. Effects of pretreatment with clopidogrel and
aspirin followed by long-term therapy in patients undergoing
percutaneous coronary intervention: The PCI-CURE study.
Lancet 2001; 358:527-33.
33. Harjai KJ, Stone GW, Boura J, Mattos L, Chandra H, Cox D,
et al. Comparison of outcomes of diabetic and nondiabetic
patients undergoing primary angioplasty for acute myocardial
infarction. Am J Cardiol 2003; 91: 1041-5.
34. Hasdai D, Granger CB, Srivatsa SS.C’riger DA, Ellis SG,
Califf RM, et al. Diabetes mellitus and outcome after primary
coronary angioplasty for acute myocardial infarction: Lessons
from the GUSTO-IIb angioplasty substudy. J Am Coll Cardiol
2000; 35:1502-12.
35. Malmberg K. Prospective randomised study of intensive insu-
lin treatment on long term survival after acute myocardial in-
farction in patients with diabetes mellitus. DIGAMI (Diabetes
Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarc-
tion) Study Group. BMJ 1997; 314:1512-5.
36. Hasdai D, Rizza RA, Grill DE, Scott CG, Garratt KN,
Holmes DR. Glycemic control and outcome of diabetic
patients after successful percutaneous coronary
revascularization. Am Heart J 2001; 141:117-23.
37. Brooks RC, Detre KM. Clinical trials of revascularization
therapy in diabetics. Curr Opin Cardiol 2000; 15:287-92.
38. BARI Investigators. Seven-year outcome in the Bypass
Angioplasty Revascularization Investigation (BARI) by treat-
ment and diabetic status. J Am Coil Cardiol 2000; 35:1122-9.
39. Mak KH, Faxon DP. Clinical studies on coronary revasculari-
zation in patients with type 2 diabetes (review article). Eur
Heart J 2003; 24:1087-103.
40. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand
VM, Limet RV, et al. Clinical and economic impact of diabetes
mellitus on percutaneous and surgical treatment of multivessel
coronary disease patients: insights for the Arterial Revascu-
larization Therapy Study (ARTS) Trial. Circulation 2001; 104:
533-8.
41. Sedlis SP, Morrison DA, Lorin JD, Esposito R, Sethi G, Sacks
J, et al. Percutaneous coronary intervention versus coronary
bypass graft surgery for diabetic patients with unstable angina
and risk factors for adverse outcomes with bypass: outcome of
diabetic patients in the AWESOME randomized trial and
registry. J Am Coll Cardiology 2002; 40:1555-66.
42. Van Domburg RT, Foley DP, Breeman A, van Herwerden LA,
Serruys PW. Coronary artery bypass graft surgery an percu-
taneous transluminal coronary angioplasty. Twenty-year clini-
cal outcome. Eur Heart J 2002; 23: 543-9.
43. Gæde P, Vedel P, Larsen N, Jensen GVH, Parving HH, Peder-
sen O. Multifactorial intervention and cardiovascular disease in
patients with type 2 diabetes. N Engl J Med 2003; 348:383-93.
232 Læknablaðið 2004/90